within Pharmacolibrary.Drugs.ATC.R;

model R06AA11
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.55,
    Cl             = 15 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,
    adminCount     = 1,
    Vd             = 0.0033,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Dimenhydrinate is an over-the-counter antihistamine used primarily to prevent and treat nausea, vomiting, and dizziness caused by motion sickness and vertigo. It is a combination of diphenhydramine and 8-chlorotheophylline. It is approved and widely used for travel-related and vestibular disturbances.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for adult healthy subjects based on known properties of parent compound (diphenhydramine) as specific PK data for dimenhydrinate is not available in published literature.</p><h4>References</h4><ol><li><p>Ehling, S, et al., &amp; Papich, MG (2019). Diphenhydramine pharmacokinetics after oral and intravenous administration of diphenhydramine and oral administration of dimenhydrinate to healthy dogs, and pharmacodynamic effect on histamine-induced wheal formation: a pilot study. <i>Veterinary dermatology</i> 30(2) 91–e24. DOI:<a href=&quot;https://doi.org/10.1111/vde.12727&quot;>10.1111/vde.12727</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30779257/&quot;>https://pubmed.ncbi.nlm.nih.gov/30779257</a></p></li><li><p>Scavone, JM, et al., &amp; Greenblatt, DJ (1990). Diphenhydramine kinetics following intravenous, oral, and sublingual dimenhydrinate administration. <i>Biopharmaceutics &amp; drug disposition</i> 11(3) 185–189. DOI:<a href=&quot;https://doi.org/10.1002/bdd.2510110302&quot;>10.1002/bdd.2510110302</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2328304/&quot;>https://pubmed.ncbi.nlm.nih.gov/2328304</a></p></li><li><p>Valoti, M, et al., &amp; Sgaragli, G (2003). Pharmacokinetics of diphenhydramine in healthy volunteers with a dimenhydrinate 25 mg chewing gum formulation. <i>Methods and findings in experimental and clinical pharmacology</i> 25(5) 377–381. DOI:<a href=&quot;https://doi.org/10.1358/mf.2003.25.5.769660&quot;>10.1358/mf.2003.25.5.769660</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12851661/&quot;>https://pubmed.ncbi.nlm.nih.gov/12851661</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end R06AA11;
